Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. APOTEX INC. (D.N.J. 2019)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. APOTEX INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-06-28 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-09-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | None | Referred To | Joel Schneider |
| Patents | 7,780,987; 8,323,692 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. APOTEX INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH IRELAND LIMITED v. APOTEX INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-06-28 | 1 | Complaint | infringement of U.S. Patent Nos. 7,780,987 (the “’987 Patent”) and 8,323,692 (the “’692 Patent”) (collectively…for infringement of the Patents-in-Suit. This action arises under the Patent Laws of the United States… THE PATENTS-IN-SUIT 15. On August 4, 2010, the ’987 Patent entitled “Controlled… the ’987 Patent are Fang Zhou and Paul Maes. According to the Orange Book, the ’987 Patent expires on… ’987 Patent is attached as Exhibit 1.) 16. On December 4, 2012, the ’692 Patent entitled | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
